On 26th May 2010, Viscofan BioEngineering announced that it has entered into a 2-year cooperation with the Department of Urology at the University Hospital of Tübingen. Under the terms of the agreement, the company’s “Collagen Cell Carrier” (CCC) will be evaluated in in vitro and pre-clinical models for its suitability as a scaffold for urothelial cells and subsequently as an urological implant. The goal of the cooperation is to enable the use of the cell-seeded CCC for the repair of urethral defects.
Initial cell culture investigations have already demonstrated the excellent suitability of CCC for the growth of human urothelial cells. These results were the basis of the cooperation agreement between the two partners.In Germany alone, around 30,000 people per year have to undergo surgery due to urethral stricture. Causes of such strictures are damage to the urethra caused by transurethral prostatectomy, pelvis injuries, permanent catheters or endoscopic interventions. Current surgical reconstruction of complicated urethral strictures uses tissue from the patient, for example buccal mucosa. The use of CCCs seeded with autologous urothelial cells has the potential to considerably reduce the post-operative stress suffered by patients and speed up recovery time.
Further information:Viscofan BioEngineeringBadeniastraße 1369469 WeinheimE-mail: contact(at)bio.viscofan.com